Genetic testing is the primary method used to detect mutations associated with autosomal dominant cancer syndromes. Testing typically involves:
- Blood or saliva samples: These samples are analyzed to identify specific gene mutations. - Next-Generation Sequencing (NGS): This advanced technology allows for the simultaneous analysis of multiple genes, making it possible to identify mutations quickly and accurately.
